NCT06277154 2025-07-24MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaHRYZ Biotech Co.Phase 2 Recruiting148 enrolled
NCT01125449 2025-05-18Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor DiseaseSitus Cancer Research CenterPhase 2 Withdrawn